Serge Marchand

Dr. Serge Marchand

orcid

Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 April 2016 in Pain
Verified
Journal Article
Closed access
SPStéphane Potvin
Stéphane Potvin
SMSerge Marchand
Serge Marchand
Although fibromyalgia (FM) is associated with a deficit in inhibitory conditioned pain modulation (CPM), the discriminative power of CPM procedures is unknown. Moreover, the high intersubject heterogeneity in CPM responses in FM raises the possibility that a sizeable subgroup of these patients may experience pain facilitation during CPM, but the phenomenon has not been explicitly studied. To address these issues, 96 patients with FM and 71 healthy controls were recruited. Thermal stimuli were used to measure pain thresholds. Pain inhibition was elicited using a tonic thermal test (Peltier thermode) administered before and after activation of CPM mechanisms using a cold pressor test. Thermal pain thresholds were lower in patients with FM than in healthy controls. Pain ratings during the cold pressor test were higher in patients with FM, relative to controls. The CPM inhibitory efficacy was lower in patients with FM than in controls. The CPM procedure had good specificity (78.9%) but low sensitivity (45.7%), whereas a composite pain index had good sensitivity (75.0%) and specificity (78.9%). Finally, the rate of patients with FM who reported pain facilitation during the CPM procedure was found to be significantly increased compared with that of controls (41.7% vs 21.2%). The good discriminative power of the composite pain index highlights the need for further validation studies using mechanistically relevant psychophysical procedures in FM. The low sensitivity of the CPM procedure, combined with the large proportion of patients with FM experiencing pain facilitation during CPM, strongly suggests that endogenous pain inhibition mechanisms are deeply impaired in patients with FM, but only in a subgroup of them.

1 December 2002 in Brain Research
Verified
Journal Article
Closed access
IGIsabelle Gaumond
Isabelle Gaumond
PAPierre Arsenault
Pierre Arsenault
SMSerge Marchand
Serge Marchand

1 December 2016 in Neuroscience
Verified
Journal Article
Closed access
MMMeggane Melchior
Meggane Melchior
PPPierrick Poisbeau
Pierrick Poisbeau
IGIsabelle Gaumond
Isabelle Gaumond
SMSerge Marchand
Serge Marchand

1 January 2018
Verified
Book Chapter
Closed access
JDJanie Damien
Janie Damien
LCLuana Colloca
Luana Colloca
CBCarmen-Édith Bellei-Rodriguez
Carmen-Édith Bellei-Rodriguez
SMSerge Marchand
Serge Marchand

27 January 2009 in Synapse
Verified
Journal Article
Closed access
PDF file
SPStéphane Potvin
Stéphane Potvin
SGSylvain Grignon
Sylvain Grignon
SMSerge Marchand
Serge Marchand

1 February 2009 in The Clinical Journal of Pain
Verified
Journal Article
Closed access
JSJuliana Barcellos de Souza
Juliana Barcellos de Souza
SPStéphane Potvin
Stéphane Potvin
PGPhilippe Goffaux
Philippe Goffaux
JCJacques Charest
Jacques Charest
SMSerge Marchand
Serge Marchand
Background On pathophysiologic grounds, fibromyalgia (FM) is characterized by a deficit in diffuse noxious inhibitory controls (DNIC), but the role of depressive symptoms on these mechanisms has not been investigated. We hypothesized that the deficit in pain inhibition would be more pronounced in FM patients with depressive symptoms (FM+D), relative to patients without such symptoms (FM−D). Methods Fifty-two women diagnosed with FM (American College of Rheumatology criteria) and 10 healthy women participated in this study. Thermal stimuli were used to measure pain thresholds and DNIC efficacy (spatial summation paradigm). Clinical pain was measured using visual analog scales. Results We found that the amplitude of DNIC was smaller in FM+D patients, relative to the FM−D group; and that daily pain (unpleasantness) was higher in the FM+D group, relative to FM−D patients. Discussion We found that FM+D patients have a more pronounced deficit in pain inhibition as well increased clinical pain. As such, these results show the usefulness of combining psychologic factors and psychophysical measures to identify subgroups of FM patients. These results may have implications for future treatment of FM patients with and without comorbid depressive symptoms.